Literature DB >> 7668222

Flow cytometric evaluation of platelet activation in blood collected into EDTA vs. Diatube-H, a sodium citrate solution supplemented with theophylline, adenosine, and dipyridamole.

T Kühne1, A Hornstein, J Semple, W Chang, V Blanchette, J Freedman.   

Abstract

With platelet activation, there is modulation of platelet surface molecule expression. In flow cytometric analyses of in vivo platelet activation, results are often confounded by activation induced in vitro by the preparative procedures. It is particularly important therefore to prevent or retard platelet activation as soon as possible after withdrawal of the blood sample. Taking blood into paraformaldehyde, or fixing the cells with paraformaldehyde as soon as possible after withdrawal, has been employed to prevent platelet activation in vitro, but paraformaldehyde-fixed platelets cannot be further used in functional studies. We investigated the efficacy of Diatube-H, a commercially available combination of platelet antagonists (theophylline, adenosine, and dipyridamole), in preventing or retarding platelet activation in vitro, along with its effects on modulation of platelet membrane glycoproteins (GP) and adhesion molecules. In contrast to blood taken into EDTA, blood taken into Diatube-H vacutainer tubes could be stored at room temperature for up to 4 hr prior to paraformaldehyde fixation without significant in vitro platelet activation, as measured by CD62P, CD63 and modulation of GPIb and GPIIbIIIa surface expression. Hence, paraformaldehyde fixation could be deferred for several hours, permitting transport of samples from distant sites. Studies of thrombin-induced platelet activation indicated that platelets taken into Diatube-H remained functional i.e. were able to be activated. Expression of the CD29, CD49b and CD31 adhesion molecules on the platelet surface was unaffected by storage in Diatube-H. The results suggest that Diatube-H may be a useful reagent for flow cytometric studies of platelets when the samples cannot be processed immediately.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7668222     DOI: 10.1002/ajh.2830500108

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  4 in total

1.  Whole blood flow cytometry measurements of in vivo platelet activation in critically-Ill patients are influenced by variability in blood sampling techniques.

Authors:  Matthew T Rondina; Colin K Grissom; Shaohua Men; Estelle S Harris; Hansjorg Schwertz; Guy A Zimmerman; Andrew S Weyrich
Journal:  Thromb Res       Date:  2011-12-16       Impact factor: 3.944

Review 2.  Systematic review of the role of angiopoietin-1 and angiopoietin-2 in Plasmodium species infections: biomarkers or therapeutic targets?

Authors:  Gerdie M de Jong; Jasper J Slager; Annelies Verbon; Jaap J van Hellemond; Perry J J van Genderen
Journal:  Malar J       Date:  2016-12-01       Impact factor: 2.979

3.  Optimized plasma preparation is essential to monitor platelet-stored molecules in humans.

Authors:  Marion Mussbacher; Waltraud C Schrottmaier; Manuel Salzmann; Christine Brostjan; Johannes A Schmid; Patrick Starlinger; Alice Assinger
Journal:  PLoS One       Date:  2017-12-08       Impact factor: 3.240

4.  Platelet activation determines angiopoietin-1 and VEGF levels in malaria: implications for their use as biomarkers.

Authors:  Judith Brouwers; Rintis Noviyanti; Rob Fijnheer; Philip G de Groot; Leily Trianty; Siti Mudaliana; Mark Roest; Din Syafruddin; Andre van der Ven; Quirijn de Mast
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.